Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

3 strategies to combat radiology’s high-deductible health plan problem

As a growing percentage of employers begin to favor high-deductible health plans (HDHP), patients are likely to start price-shopping for imaging tests. This may pose a threat to radiology practices, particularly those based in hospitals, wrote authors of a new Journal of the American College of Radiology study.

Thumbnail

Best cardiovascular hospitals in 2019: New York, North Carolina institutions top list

IBM Watson Health has released its annual 50 Top Cardiovascular Hospitals Study, marking the 20th year the healthcare company has ranked the best-performing cardiovascular teaching and community hospitals in the U.S.

Thumbnail

Can AI make doctors obsolete? Yes and no

In a head-to-head commentary piece recently published in The BMJ, three researchers argued if AI's impact could eventually cause physicians to become obsolete.

Thumbnail

AI developer Visla Labs announces $3M in funding to grow business

Visla Labs, a San Francisco, California-based startup focused on the use of artificial intelligence (AI) in radiology, has raised $3 million in funding to “grow its team, scale product features, attain regulatory approval and fuel expansion and growth.” 

Thumbnail

Harvard: AI may help solve healthcare's red-tape problem

Artificial intelligence may help stop the “downward spiral in productivity” in the healthcare system that has been plagued by labor-intensive, inefficient administrative tasks, according to an article in the Harvard Business Review.

Thumbnail

Elections yield mixed results for America’s heart health

While many Americans were fixated on the Congressional races during the Nov. 6 midterm elections, the American Heart Association and CEO Nancy Brown kept an eye on ballot measures with implications for cardiovascular health.

Thumbnail

Could Canada afford PCSK9 inhibitors for all its eligible patients?

A clinical and economic analysis of PCSK9 inhibitors in Canadian patients with atherosclerotic cardiovascular disease (ASCVD) is solidifying physician concerns that the lipid-lowering drugs might be too inaccessible—or too pricey—to benefit the average heart patient.

Thumbnail

Perspective: Ethical challenges must be addressed with machine learning

Before healthcare providers go all-in with machine learning, the technology needs to align with safety and ethical standards, according to a recent perspective published in PLOS Medicine.